Search | SciELO

Resumo Objetivos: avaliar a assistência pré-natal prestada a gestantes de baixo risco usuárias do Sistema Único de Saúde da cidade de Joinville – SC. Métodos: trata-se de um estudo observacional transversal realizado de março de 2018 a fevereiro de 2019, mediante entrevista e análise do Cartão da Gestante de puérperas maiores de 18 anos, procedentes de Joinville, que realizaram o pré-natal no SUS, sendo excluídas puérperas desistentes. Avaliou-se a assistência pré-natal mediante critérios preconizados pelo Programa de Humanização no Pré-natal e Nascimento. Resultados: foram entrevistadas 683 puérperas. Os critérios com maiores índices de adequação foram acessibilidade (99,6%), início precoce do pré-natal (92,7%) e realização de 6 ou mais consultas (87,1%) e os critérios que apresentaram as menores taxas de adequação foram o conjunto de orientações (17,7%) e os exames do terceiro e primeiro trimestre (42,5% e 63,5% respectivamente). Conclusão: conclui-se que a assistência pré-natal realizada pelo SUS da cidade de Joinville, não obstante da acessibilidade praticamente universal, do início precoce e da prevalência de puérperas com mais de 6 consultas, demonstrou declínio acentuado na análise dos indicadores preconizados.

Abstract Objectives: to evaluate prenatal care provided to low-risk pregnant women users of the Sistema Único de Saúde (SUS) (Public Health System) in the city of Joinville, SC. Methods: this is a cross-sectional observational study carried out from March 2018 to February 2019, through interview and analysis of the Pregnant Card of puerperal over 18 years old, from Joinville, who underwent prenatal care at SUS, excluding recent given up puerperal. Prenatal care was evaluated according to the recommended criteria by the Prenatal and Birth Humanization Program. Results: 683 mothers were interviewed. The criteria with the highest levels of adequacy were accessibility (99.6%), early initiation on prenatal care (92.7%) and 6 or more consultations (87.1%) and the criteria with the lowest rates of adequacy were the set of guidelines (17.7%) and the third and first trimester exams (42.5% and 63.5% respectively). Conclusion: it is concluded that the prenatal care provided by SUS in the city of Joinville, despite the almost universal accessibility, the early onset and the prevalence of puerperal women with more than 6 consultations, showed a sharp decline in the analysis of the recommended indicators.

https://doi.org/10.1590/1806-93042021000200006 155 downloads

Diretrizes brasileiras para o manejo de potenciais doadores de órgãos em morte encefálica. Uma força-tarefa composta por Associação de Medicina Intensiva Brasileira, Associação Brasileira de Transplantes de Órgãos, Brazilian Research in Critical Care Network e Coordenação Geral do Sistema Nacional de Transplantes
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Westphal, Glauco Adrieno

; Robinson, Caroline Cabral

; Cavalcanti, Alexandre Biasi

; Gonçalves, Anderson Ricardo Roman

; Guterres, Cátia Moreira

; Teixeira, Cassiano

; Stein, Cinara

; Franke, Cristiano Augusto

; Silva, Daiana Barbosa da

; Pontes, Daniela Ferreira Salomão

; Nunes, Diego Silva Leite

; Abdala, Edson

; Dal-Pizzol, Felipe

; Bozza, Fernando Augusto

; Machado, Flávia Ribeiro

; Andrade, Joel de

; Cruz, Luciane Nascimento

; Azevedo, Luciano César Pontes

; Machado, Miriam Cristine Vahl

; Rosa, Regis Goulart

; Manfro, Roberto Ceratti

; Nothen, Rosana Reis

; Lobo, Suzana Margareth

; Rech, Tatiana Helena

; Lisboa, Thiago Costa

; Colpani, Verônica

; Falavigna, Maicon

Revista Brasileira de Terapia Intensiva

Journal Metrics
- Sobre o periódico
- SciELO Analytics

jan 2021, Volume 33 N. 1 Pages 1 - 11

Abstract: Pt En | Text: Pt En | PDF: Pt | PDF: En

RESUMO Objetivo: Fornecer recomendações para nortear o manejo clínico do potencial doador em morte encefálica. Métodos: O presente documento foi formulado em dois painéis compostos por uma força tarefa integrada por 27 especialistas de diferentes áreas que responderam a questões dirigidas aos seguintes temas: ventilação mecânica, hemodinâmica, suporte endócrino-metabólico, infecção, temperatura corporal, transfusão sanguínea, e uso de checklists. Os desfechos considerados foram: parada cardíaca, número de órgãos retirados ou transplantados e função/sobrevida dos órgãos transplantados. A qualidade das evidências das recomendações foi avaliada pelo sistema Grading of Recommendations Assessment, Development, and Evaluation. Resultados: Foram geradas 19 recomendações a partir do painel de especialistas. Dessas, 7 foram classificadas como fortes, 11 fracas e uma foi considerada boa prática clínica. Conclusão: Apesar da concordância entre os membros do painel em relação à maior parte das recomendações, o grau de recomendação é fraco em sua maioria.

Abstract Objective: To contribute to updating the recommendations for brain-dead potential organ donor management. Methods: A group of 27 experts, including intensivists, transplant coordinators, transplant surgeons, and epidemiologists, answered questions related to the following topics were divided into mechanical ventilation, hemodynamics, endocrine-metabolic management, infection, body temperature, blood transfusion, and checklists use. The outcomes considered were cardiac arrests, number of organs removed or transplanted as well as function / survival of transplanted organs. The quality of evidence of the recommendations was assessed using the Grading of Recommendations Assessment, Development, and Evaluation system to classify the recommendations. Results: A total of 19 recommendations were drawn from the expert panel. Of these, 7 were classified as strong, 11 as weak and 1 was considered a good clinical practice. Conclusion: Despite the agreement among panel members on most recommendations, the grade of recommendation was mostly weak.

https://doi.org/10.5935/0103-507x.20210001 742 downloads

A post-incorporation study on the use of palivizumab in the Brazilian public health system
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Batista, Joanna d’Arc Lyra

; Ferreira, Maria Angélica Pires

; Xavier, Cilene da Silva

; Souza, Ires Tarsila Alves de

; Cruz, Luciane Nascimento

; Polanczyk, Carisi Anne

Revista do Instituto de Medicina Tropical de São Paulo

Journal Metrics
- Sobre o periódico
- SciELO Analytics

2021, Volume 63 elocation e5

Abstract: En | Text: En | PDF: En

ABSTRACT Respiratory syncytial virus (RSV) is the main cause of lower respiratory disease in infants and children under five years of age. As there is no specific treatment for RSV infections, prophylaxis with the specific monoclonal antibody palivizumab (PVZ) has been widely recommended for high-risk cases during the RSV season. The present study aimed to evaluate the effectiveness of a public prophylaxis program with palivizumab on the incidence of hospitalizations for lower respiratory tract infections and RSV in children at high risk for severe RSV infections. A retrospective cohort study was carried out with preterm children or children under two years of age with chronic lung disease or hemodynamically significant congenital heart disease; the children were selected on the basis of their exposure status, which was defined as the prophylactic use of palivizumab during the RSV season. Children were enrolled retrospectively in two hospitals located in Southern Brazil, from May 2009 to August 2016. In a sample of 129 children, 69 (53.5%) received palivizumab and adherence to three or more doses was observed in 78%; 60 (46.5%) children did not receive palivizumab. PVZ prophylaxis was independently associated with a 66% reduction in hospitalizations for any cause (26/69 - 37.7%) in the PVZ group and 34/60 (56.7%) in the control group). A 52% reduction in hospitalizations due to lower respiratory tract infection was observed in the PVZ group (15/69 -21.7%) and 25/60 (41.7%) in the control group. These findings suggest that, for the group of studied patients, the adoption of an RSV prophylaxis scheme reached the same effectiveness as those described in previous clinical trials.

https://doi.org/10.1590/s1678-9946202163005 608 downloads

The cost of a disease targeted for elimination in Brazil: the case of schistosomiasis mansoni
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Nascimento, Gilmara Lima

; Pegado, Helio Milani

; Domingues, Ana Lúcia Coutinho

; Ximenes, Ricardo Arraes de Alencar

; Itria, Alexander

; Cruz, Luciane Nascimento

; Oliveira, Maria Regina Fernandes de

Memórias do Instituto Oswaldo Cruz

Journal Metrics
- Sobre o periódico
- SciELO Analytics

2019, Volume 114 elocation e180347

Abstract: En | Text: En | PDF: En

BACKGROUND Schistosomiasis mansoni is a poverty-related parasitic infection that has a variety of clinical manifestations. We consider the disability and deaths caused by schistosomiasis unacceptable for a tool-ready disease. Its condition in Brazil warrants an analysis that will enable better understanding of the local health losses and contribute to the complex decision-making process. OBJECTIVE This study estimates the cost of schistosomiasis in Brazil in 2015. METHODS We conducted a cost of illness study of schistosomiasis mansoni in Brazil in 2015 based on a prevalence approach and from a societal perspective. The study included 26,499 schistosomiasis carriers, 397 hepatosplenic cases, 48 cases with the neurological form, 284 hospitalisations, and 11,368.26 years of life lost (YLL) of which 5,187 years are attributable to economically active age groups. RESULTS The total cost of schistosomiasis mansoni in Brazil was estimated to be US$ 41,7million in 2015 with 94.61% of this being indirect costs. CONCLUSIONS The economic burden of schistosomiasis mansoni in Brazil is high and results in the loss of productivity. Its persistence in Brazil is a challenge to public health and requires inter-sectorial interventions in areas such as indoor water supply, basic sanitation, and education.

https://doi.org/10.1590/0074-02760180347 1619 downloads

Qualidade de vida pós-unidades de terapia intensiva: protocolo de estudo de coorte multicêntrico para avaliação de desfechos em longo prazo em sobreviventes de internação em unidades de terapia intensiva brasileiras
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Robinson, Caroline Cabral

; Rosa, Regis Goulart

; Kochhann, Renata

; Schneider, Daniel

; Sganzerla, Daniel

; Dietrich, Camila

; Sanchez, Évelin Carneiro

; Dutra, Francine Hoffmann

; Oliveira, Maicon Quadro de

; Anzolin, Luisa Barbosa

; Menezes, Suelen Fardim de

; Jeffman, Rodrigo

; Souza, Denise de

; Silva, Sâmia Faria da

; Cruz, Luciane Nascimento

; Boldo, Rodrigo

; Cardoso, Juliana Rezende

; Birriel, Daniella Cunha

; Gamboa, Mariana Nunes

; Machado, André Sant'Ana

; Andrade, Juliana Mara Stormosvski de

; Alencar, Cesar

; Teixeira, Michelle Carneiro

; Vieira, Silvia Regina Rios

; Moreira, Fernanda Caleffe

; Amaral, Alexandre

; Silveira, Ana Paula Menezes

; Teles, José Mario Meira

; Oliveira, Daniela Cunha de

; Oliveira Júnior, Lúcio Couto de

; Castro, Lívia Correa e

; Silva, Marli Sarmento da

; Neves, Rafael Trevizoli

; Gomes, Renata de Andrade

; Ribeiro, Cinthia Mucci

; Cavalcanti, Alexandre Biasi

; Oliveira, Roselaine Pinheiro de

; Maccari, Juçara Gasparetto

; Berto, Paula Pinheiro

; Martins, Lucieda Araújo

; Santos, Rui Leandro da Silva

; Ue, Luciana Yumi

; Hammes, Luciano Serpa

; Sharshar, Tarek

; Bozza, Fernando

; Falavigna, Maicon

; Teixeira, Cassiano

Revista Brasileira de Terapia Intensiva

Journal Metrics
- Sobre o periódico
- SciELO Analytics

dec 2018, Volume 30 N. 4 Pages 405 - 413

Abstract: Pt En | Text: Pt En | PDF: Pt | PDF: En

RESUMO Objetivo: Avaliar a prevalência de incapacidades físicas, cognitivas e psiquiátricas, fatores associados e sua relação com qualidade de vida em pacientes sobreviventes de internação em unidades de terapia intensiva brasileiras. Métodos: Um estudo de coorte prospectivo multicêntrico está sendo conduzido em dez unidades de terapia intensiva adulto clínico-cirúrgicas representativas das cinco regiões geopolíticas do Brasil. Pacientes com idade ≥ 18 anos que receberam alta das unidades de terapia intensiva participantes e permaneceram internados na unidade de terapia intensiva por 72 horas ou mais, nos casos de internação clínica ou cirúrgica de urgência, e por 120 horas ou mais, nos casos de internação cirúrgica eletiva, serão incluídos de forma consecutiva. Estes pacientes serão seguidos por 1 ano, por meio de entrevistas telefônicas estruturadas 3, 6 e 12 meses pós-alta da unidade de terapia intensiva. Dependência funcional, disfunção cognitiva, sintomas de ansiedade e depressão, sintomas de estresse pós-traumático, qualidade de vida relacionada à saúde, re-hospitalizações e mortalidade em longo prazo serão avaliados como desfechos. Discussão: O presente estudo tem o potencial de contribuir para o conhecimento a respeito da prevalência e dos fatores associados à síndrome pós-cuidados intensivos na população de pacientes adultos sobreviventes de internação em unidades de terapia intensiva brasileiras. Ademais, a associação entre síndrome pós-cuidados intensivos e qualidade de vida relacionada à saúde poderá ser estabelecida.

ABSTRACT Objective: To establish the prevalence of physical, cognitive and psychiatric disabilities, associated factors and their relationship with the qualities of life of intensive care survivors in Brazil. Methods: A prospective multicenter cohort study is currently being conducted at 10 adult medical-surgical intensive care units representative of the 5 Brazilian geopolitical regions. Patients aged ≥ 18 years who are discharged from the participating intensive care units and stay 72 hours or more in the intensive care unit for medical or emergency surgery admissions or 120 hours or more for elective surgery admissions are consecutively included. Patients are followed up for a period of one year by means of structured telephone interviews conducted at 3, 6 and 12 months after discharge from the intensive care unit. The outcomes are functional dependence, cognitive dysfunction, anxiety and depression symptoms, posttraumatic stress symptoms, health-related quality of life, rehospitalization and long-term mortality. Discussion: The present study has the potential to contribute to current knowledge of the prevalence and factors associated with postintensive care syndrome among adult intensive care survivors in Brazil. In addition, an association might be established between postintensive care syndrome and health-related quality of life.

https://doi.org/10.5935/0103-507x.20180063 7824 downloads

Associação entre o tipo de aleitamento na alta hospitalar do recém-nascido e aos seis meses de vida
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Cruz, Neusa Aparecida Casetto Vieira da

; Reducino, Lucas Miotto

; Probst, Livia Fernandes

; Guerra, Luciane Miranda

; Ambrosano, Gláucia Maria Bovi

; Cortellazzi, Karine Laura

; Ribeiro-Dasilva, Margarete C.

; Tomar, Scott L.

; Cunha, Inara Pereira da

; Possobon, Rosana de Fátima

Cadernos Saúde Coletiva

Journal Metrics
- Sobre o periódico
- SciELO Analytics

jun 2018, Volume 26 N. 2 Pages 117 - 124

Abstract: Pt En | Text: Pt En | PDF: Pt | PDF: En

Resumo Introdução Os índices de aleitamento materno no Brasil permanecem muito abaixo dos considerados ideais, fazendo-se necessário o entendimento das variáveis envolvidas na fragmentação do aleitamento ao longo dos meses de vida da criança. Objetivo Objetivou-se, neste estudo, verificar a associação entre o tipo de aleitamento no momento da alta hospitalar do recém-nascido e a prática da amamentação aos seis meses de vida. Método Estudo transversal, com dados coletados do prontuário clínico de 301 crianças participantes de um programa de incentivo ao aleitamento materno. Foram considerados os fatores de risco e de proteção ao aleitamento, tais como: idade dos pais, presença do companheiro, paridade, renda familiar, permanência em alojamento conjunto, tempo decorrido do nascimento até a primeira mamada, tempo de hospitalização, tipo de amamentação na alta hospitalar e uso de chupeta ao longo dos seis meses de vida. Resultados Os resultados mostraram haver associação significativa entre aleitamento materno exclusivo na alta hospitalar e aos seis meses de idade (p=0,0205). Conclusão A observação desses dados permite concluir que é importante que, ao deixar a maternidade, o bebê esteja em amamentação exclusiva, pois, dessa forma, terá 2,5 vezes mais chances de manter esse tipo de aleitamento até os seis meses de vida.

Abstract Introduction Breastfeeding rates in Brazil remain far below those considered ideal, making it necessary understanding the variables involved in the fragmentation of this process over the months of a child’s life. Objective The objective of this study was to investigate the association between type of breastfeeding of newborns at hospital discharge and at six months of age. Method A cross-sectional study with data collected from the medical records of 301 children participating in a program to encourage exclusive breastfeeding. The study considered risk and protection factors to breastfeeding such as age of parents, presence of mate, parity, family income, stay in room, time elapsed from birth to first breastfeeding, hospitalization time, type of breastfeeding at hospital discharge, and use of pacifier until the age of six months. Results The results revealed significant correlation between exclusive breastfeeding at hospital discharge and at six months of age (p=0.0205). Conclusion Observation of data enabled the following conclusion: it is important that newborns undergo exclusive breastfeeding after hospital discharge because, this way, they will be 2.5 times more likely to maintain this type of feeding until the age of six months.

https://doi.org/10.1590/1414-462x201800020349 2485 downloads

Biological drugs for the treatment of psoriasis in a public health system
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Lopes, Luciane Cruz

; Silveira, Miriam Sanches do Nascimento

; Camargo, Iara Alves de

; Barberato-Filho, Silvio

; Del Fiol, Fernando de Sá

; Osorio-de-Castro, Claudia Garcia Serpa

Revista de Saúde Pública

Journal Metrics
- Sobre o periódico
- SciELO Analytics

aug 2014, Volume 48 N. 4 Pages 651 - 661

Abstract: Pt En | Text: Pt En | PDF: Pt | PDF: En

OBJETIVO Analisar o acesso e o perfil de utilização, por via judicial, de medicamentos biológicos para o tratamento de psoríase. MÉTODOS Estudo transversal descritivo. Foram entrevistados 203 pacientes com psoríase que demandaram medicamentos biológicos, por via judicial, ao Estado de São Paulo, entre 2004 e 2010. Informações sobre características sociodemográficas, médico-sanitárias e político-administrativas foram complementadas com dados obtidos das respectivas ordens de dispensação quanto a medicamento biológico para tratamento de psoríase e autos correspondentes. Os dados foram analisados em banco eletrônico e as variáveis sumarizadas por frequência simples. As prescrições contidas nos processos foram analisadas quanto aos preceitos legais contidos na lei. RESULTADOS Foram analisados 190 autos referentes aos medicamentos biológicos: adalimumabe, efalizumabe, etanercepte e infliximabe. Os proponentes obtiveram o medicamento por mandado de segurança (59,5%), sem nunca ter solicitado o medicamento biológico para outra instituição (86,2%), por sistema de saúde público ou privado. Utilizaram-se da prerrogativa de gratuidade de justiça (72,6%), embora fossem representados por advogado particular (91,1%) e atendidos em consultórios médicos privados (69,5%). Utilizaram o medicamento biológico por período > 13 meses (66,0%) e 44,9% faziam uso do medicamento no momento da entrevista. Quase um terço daqueles que deixaram de usar os medicamentos abandonou o tratamento por piora do quadro (26,6%), efeitos adversos (20,5%), falta de eficácia ou suspensão pelo médico (13,8%). Nenhuma prescrição médica atendeu aos preceitos legais; 70,3% dos pacientes não haviam realizado exames laboratoriais (hemograma, função hepática e renal) para controle do tratamento. CONCLUSÕES Os demandantes recorreram à via judicial para obtenção de medicamentos biológicos por desconhecimento ou por dificuldades de acesso pelas vias institucionais do sistema público de saúde O acesso facilitado pela via judicial favorece o uso do medicamento por tempo prolongado por meio de prescrições não conformes, frequência elevada de efeitos adversos e monitoramento clínico inadequado.

OBJECTIVE To analyze the access and utilization profile of biological medications for psoriasis provided by the judicial system in Brazil. METHODS This is a cross-sectional study. We interviewed a total of 203 patients with psoriasis who were on biological medications obtained by the judicial system of the State of Sao Paulo, from 2004 to 2010. Sociodemographics, medical, and political-administrative characteristics were complemented with data obtained from dispensation orders that included biological medications to treat psoriasis and the legal actions involved. The data was analyzed using an electronic data base and shown as simple variable frequencies. The prescriptions contained in the lawsuits were analyzed according to legal provisions. RESULTS A total of 190 lawsuits requesting several biological drugs (adalimumab, efalizumab, etanercept, and infliximab) were analyzed. Patients obtained these medications as a result of injunctions (59.5%) or without having ever demanded biological medication from any health institution (86.2%), i.e., public or private health services. They used the prerogative of free legal aid (72.6%), even though they were represented by private lawyers (91.1%) and treated in private facilities (69.5%). Most of the patients used a biological medication for more than 13 months (66.0%), and some patients were undergoing treatment with this medication when interviewed (44.9%). Approximately one third of the patients discontinued treatment due to worsening of their illness (26.6%), adverse drug reactions (20.5%), lack of efficacy, or because the doctor discontinued this medication (13.8%). None of the analyzed medical prescriptions matched the legal prescribing requirements. Clinical monitoring results showed that 70.3% of the patients had not undergone laboratory examinations (blood work, liver and kidney function tests) for treatment control purposes. CONCLUSIONS The plaintiffs resorted to legal action to get access to biological medications because they were either unaware or had difficulty in accessing them through institutional public health system procedures. Access by means of legal action facilitated long-term use of this type of medication through irregular prescriptions and led to a high rate of adverse drug reactions as well as inappropriate clinical monitoring.

https://doi.org/10.1590/S0034-8910.2014048005109 3871 downloads Cited 1 time in SciELO

Biological drugs for the treatment of psoriasis in a public health system
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Lopes, Luciane Cruz

; Silveira, Miriam Sanches do Nascimento

; Camargo, Iara Alves de

; Barberato-Filho, Silvio

; Del Fiol, Fernando de Sá

; Osorio-de-Castro, Claudia Garcia Serpa

Revista de Saúde Pública

Journal Metrics
- Sobre o periódico
- SciELO Analytics

aug 2014, Volume 48 N. 4 Pages 651 - 661

Abstract: Pt En | Text: Pt En | PDF: Pt | PDF: En

OBJETIVO Analisar o acesso e o perfil de utilização, por via judicial, de medicamentos biológicos para o tratamento de psoríase.MÉTODOS Estudo transversal descritivo. Foram entrevistados 203 pacientes com psoríase que demandaram medicamentos biológicos, por via judicial, ao Estado de São Paulo, entre 2004 e 2010. Informações sobre características sociodemográficas, médico-sanitárias e político-administrativas foram complementadas com dados obtidos das respectivas ordens de dispensação quanto a medicamento biológico para tratamento de psoríase e autos correspondentes. Os dados foram analisados em banco eletrônico e as variáveis sumarizadas por frequência simples. As prescrições contidas nos processos foram analisadas quanto aos preceitos legais contidos na lei.RESULTADOS Foram analisados 190 autos referentes aos medicamentos biológicos: adalimumabe, efalizumabe, etanercepte e infliximabe. Os proponentes obtiveram o medicamento por mandado de segurança (59,5%), sem nunca ter solicitado o medicamento biológico para outra instituição (86,2%), por sistema de saúde público ou privado. Utilizaram-se da prerrogativa de gratuidade de justiça (72,6%), embora fossem representados por advogado particular (91,1%) e atendidos em consultórios médicos privados (69,5%). Utilizaram o medicamento biológico por período > 13 meses (66,0%) e 44,9% faziam uso do medicamento no momento da entrevista. Quase um terço daqueles que deixaram de usar os medicamentos abandonou o tratamento por piora do quadro (26,6%), efeitos adversos (20,5%), falta de eficácia ou suspensão pelo médico (13,8%). Nenhuma prescrição médica atendeu aos preceitos legais; 70,3% dos pacientes não haviam realizado exames laboratoriais (hemograma, função hepática e renal) para controle do tratamento.CONCLUSÕES Os demandantes recorreram à via judicial para obtenção de medicamentos biológicos por desconhecimento ou por dificuldades de acesso pelas vias institucionais do sistema público de saúde O acesso facilitado pela via judicial favorece o uso do medicamento por tempo prolongado por meio de prescrições não conformes, frequência elevada de efeitos adversos e monitoramento clínico inadequado.

OBJECTIVE To analyze the access and utilization profile of biological medications for psoriasis provided by the judicial system in Brazil.METHODSThis is a cross-sectional study. We interviewed a total of 203 patients with psoriasis who were on biological medications obtained by the judicial system of the State of Sao Paulo, from 2004 to 2010. Sociodemographics, medical, and political-administrative characteristics were complemented with data obtained from dispensation orders that included biological medications to treat psoriasis and the legal actions involved. The data was analyzed using an electronic data base and shown as simple variable frequencies. The prescriptions contained in the lawsuits were analyzed according to legal provisions.RESULTS A total of 190 lawsuits requesting several biological drugs (adalimumab, efalizumab, etanercept, and infliximab) were analyzed. Patients obtained these medications as a result of injunctions (59.5%) or without having ever demanded biological medication from any health institution (86.2%), i.e., public or private health services. They used the prerogative of free legal aid (72.6%), even though they were represented by private lawyers (91.1%) and treated in private facilities (69.5%). Most of the patients used a biological medication for more than 13 months (66.0%), and some patients were undergoing treatment with this medication when interviewed (44.9%). Approximately one third of the patients discontinued treatment due to worsening of their illness (26.6%), adverse drug reactions (20.5%), lack of efficacy, or because the doctor discontinued this medication (13.8%). None of the analyzed medical prescriptions matched the legal prescribing requirements. Clinical monitoring results showed that 70.3% of the patients had not undergone laboratory examinations (blood work, liver and kidney function tests) for treatment control purposes.CONCLUSIONS The plaintiffs resorted to legal action to get access to biological medications because they were either unaware or had difficulty in accessing them through institutional public health system procedures. Access by means of legal action facilitated long-term use of this type of medication through irregular prescriptions and led to a high rate of adverse drug reactions as well as inappropriate clinical monitoring.

https://doi.org/10.1590/S0034-8910.2014048005109 19845 downloads

Metabolic syndrome components can predict C reactive protein concentration in adolescents
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Leandro da Cruz, Larissa

; Cardoso, Luciane Daniele

; Pala, Daniela

; Paula, Heberth de

; Alves Lamounier, Joel

; Mariano Silva, Camilo Adalton

; Pinheiro Volp, Ana Carolina

; Nascimento de Freitas, Renata

Nutrición Hospitalaria

Journal Metrics
- Sobre o periódico
- SciELO Analytics

oct 2013, Volume 28 N. 5 Pages 1580 - 1586

Abstract: En Es | Text: En Es | PDF: En | PDF: Es

Background: Metabolic syndrome (MS) is suggested to be associated with a low grade inflammation state, but the relationship between inflammation biomarkers and the components of metabolic syndrome in adolescents are still lacking. Objective: To investigate the association between C-reactive protein (CRP) serum concentrations and metabolic syndrome components in adolescents. Methods: A cross-sectional population based study was conducted. Anthropometric, biochemical and clinical data were collected from 524 adolescents (11-15 years old) randomly sampled from school population of Alegre city, Espmto Santo, Brazil. Data were analyzed by STATA version 9.0. Results: Adolescents with higher values for BMI (p = 0.001) and higher body fat percentage (p = 0.003) had higher CRP concentrations than those with lower BMI and body fat percentage. CRP concentrations was directly correlated with BMI (r = 0.17, p = 0.0001), waist circumference (r = 0.15, p = 0.0005), HDL-c (r = 0.13, p = 0.003), fasting insulin (r = 0.12, p = 0.003) and systolic blood pressure (r = 0.11, p with = 0.01). In the multiple linear regression analysis BMI (r = 0.05, p = 0.002), fasting glucose (r = -0.01, p = 0.003) and HDL-c (r = 0.017, p < 0.001) were associated to CRP concentrations after adjusting for the other components of MS. Conclusion: The association found between individual components of MS and CRP concentrations suggests that inflammation might be an early event in the development of metabolic disorders in adolescents.

Antecedentes: El síndrome metabólico (SM) se sugiere que está asociada con un estado de inflamación crónica de bajo grado, pero la relación entre biomarcadores de inflamación crónica de bajo grado, pero la relación entre biomarcadores de inflamación y los componentes del síndrome metabólico en adolescentes son escasos. Objetivo: Investigar la asociación entre las concentraciones séricas de proteína C reactiva (CRP) y los componentes del síndrome metabólico en adolescentes. Metodología: Hemos realizado una población basada en estudio de corte transversal. Los datos antropométricos, bioquímicos y clínicos se obtuvieron de 524 adolescentes (11-15 años de edad) seleccionados al azar de la población escolar de la ciudad Alegre, Espírito Santo, Brasil. Los datos fueron analizados por STATA versión 9.0. Resultados: Los adolescentes, con valores más altos de IMC (p = 0,001) y mayor porcentaje de grasa corporal (p = 0,003) tuvieron mayores concentraciones de PCR que aquellos con menor IMC y porcentaje de grasa corporal. Las concentraciones de PCR se correlacionó directamente con el IMC (r = 0,17, p = 0,0001), la circunferencia de la cintura (r = 0,15, p = 0,0005), HDL-c (r = 0,13, p = 0,003), la insulina en ayunas (r = 0,12, p = 0,009) y la presión arterial sistólica (r = 0,11, p = a 0,01). En el análisis de regresión lineal múltiple IMC (r = 0,05, p = 0,002), la glucosa en ayunas (r = -0,01, p = 0,003) y HDL-c (r = 0,017, p < 0,001) se asociaron a las concentraciones de PCR después de ajustar por los otros componentes de SM. Conclusión: La asociación encontrada entre los componentes individuales de SM y las concentraciones de PCR sugiere que la inflamación podría ser un evento temprano en el desarrollo de trastornos metabólicos en los adolescentes.

https://doi.org/10.3305/nh.2013.28.5.6625 367 downloads

10.

Health-related quality of life in Brazil: normative data for the SF-36 in a general population sample in the south of the country
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics

Cruz, Luciane Nascimento

; Fleck, Marcelo Pio de Almeida

; Oliveira, Michele Rosana

; Camey, Suzi Alves

; Hoffmann, Juliana Feliciati

; Bagattini, Ângela Maria

; Polanczyk, Carisi Anne

Ciência & Saúde Coletiva

Journal Metrics
- Sobre o periódico
- SciELO Analytics

jul 2013, Volume 18 N. 7 Pages 1911 - 1921

Abstract: Pt En | Text: Pt En | PDF: Pt | PDF: En

O objetivo deste trabalho foi disponibilizar escores normativos do SF-36 em uma amostra da população geral no Brasil e descrever as diferenças de escores médios de acordo com características sociodemográficas. O questionário SF-36 foi aplicado a uma amostra aleatória da população geral de Porto Alegre. A taxa de resposta foi de 68% e 755 indivíduos foram incluídos, 38% homens e 62% mulheres. O pior estado de saúde foi visto em mulheres, em indivíduos na faixa etária de 30 a 44 anos, de uma classe econômica mais baixa, com menor escolaridade e com autorrelato de uma condição médica crônica. Os resultados dos escores do SF-36 são apresentados como dados normativos para a população geral. O SF-36 foi um instrumento aceitável e prático para medir a qualidade de vida relacionada à saúde. Os resultados deste estudo podem ser úteis para pesquisadores utilizando o SF-36 em outros grupos para comparar os escores com dados normativos, ele pode ser uma boa ferramenta para detectar grupos vulneráveis em estudos epidemiológicos, pela capacidade de discriminar diferentes subgrupos da população.

The objective of this study was to provide normative SF-36 scores in a general population sample in Brazil and to describe differences in mean scores according to socio-demographic characteristics. The SF-36 questionnaire was distributed to a randomly selected sample of the general population of Porto Alegre in the State of Rio Grande do Sul. The response rate was 68% and 755 subjects were included (38% male, 62% female). Lower health status was revealed among females in the 30 to 44 year age bracket, from the lower income class, with less education and self-reported chronic medical conditions. The results and percentiles of scores of the SF-36 are reported as normative data for the general population. The SF-36 was an acceptable and practical instrument for measuring health-related quality of life in a sample of Brazilians. The results of this study can be useful for researchers using the SF-36 questionnaire in other groups to compare the scores with normative data. The SF-36 may prove a valuable tool for discovering vulnerable groups in epidemiological studies due to the ability to discriminate between different population subgroups.

5995 downloads Cited 15 times in SciELO

11.

Health-related quality of life in Brazil: normative data for the SF-36 in a general population sample in the south of the country
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Cruz, Luciane Nascimento

; Fleck, Marcelo Pio de Almeida

; Oliveira, Michele Rosana

; Camey, Suzi Alves

; Hoffmann, Juliana Feliciati

; Bagattini, Ângela Maria

; Polanczyk, Carisi Anne

Ciência & Saúde Coletiva

Journal Metrics
- Sobre o periódico
- SciELO Analytics

jul 2013, Volume 18 N. 7 Pages 1911 - 1921

Abstract: Pt En | Text: Pt En | PDF: Pt | PDF: En

https://doi.org/10.1590/S1413-81232013000700006 1137 downloads Cited 15 times in SciELO

12.

Economic evaluation in the field of mental health: conceptual basis
Facebook Twitter

Other social networks
Google+
LinkedIn
Reddit
StambleUpon
CiteULike
Mendeley
Other networks

Metrics
- SciELO Analytics
- Dimensions
- PlumX
- Altmetric

Lima, Ana Flávia Barros da Silva

; Cruz, Luciane Nascimento

; Polanczyk, Carisi Anne

; Maia, Carlos Renato Moreira

Brazilian Journal of Psychiatry

Journal Metrics
- Sobre o periódico
- SciELO Analytics

jun 2013, Volume 35 N. 2 Pages 186 - 192

Abstract: En | Text: En | PDF: En

Objective: Technological advances in medicine have given rise to a dilemma concerning the use of new health technologies in a context of limited financial resources. In the field of psychiatry, health economic evaluation is a recent method that can assist in choosing interventions with different cost and/or effectiveness for specific populations or conditions. This article introduces clinicians to the fundamental concepts required for critical assessment of health economic evaluations. Methods: The authors conducted a review with systematic methods to assess the essential theoretical framework of health economic evaluation and mental health in Brazil through textbooks and studies indexed in the PubMed, Cochrane Central, LILACS, NHS CRD, and REBRATS databases. A total of 334 studies were found using the specified terms (MeSH - Mental Health AND Economic, Medical) and filters (Brazil AND Humans); however, only five Brazilian economic evaluations were found. Results and conclusions: Economic evaluation studies are growing exponentially in the medical literature. Publications focusing on health economics as applied to psychiatry are increasingly common, but Brazilian data are still very incipient. In a country where financial resources are so scarce, economic analyses are necessary to ensure better use of public resources and wider population access to effective health technologies.

https://doi.org/10.1590/1516-4446-2012-0989 5162 downloads

Showing

itens per page

Page of 1 Next

Select one or more results

All Alphabetic

Results

Comparative chart Download CSV

Statistics of

Send result

To*

Use ; (semicolon) to insert more emails.

Send to email

This page

Selected records

All references (max. 300)

Your email

Subject

Comments

Export format:

RIS (for EndNote, ProCite, Reference Manager, RefWorks, Citavi, etc.)

BibTeX

Citation

CSV (for Excel, etc)

Export:

This page

Selected itens

All references (max. 2000)

Sem resultados

No documents were found for your search

Glossary and search help

You can enrich your search in a very simple way. Use the search indexes combined with the connectors (AND or OR) and specify more your search.

For example, if you want to search for articles about
cases of dengue in Brasil in 2015, use:
ti:dengue and publication_year:2015 and aff_country:Brasil

See below the complete list of search indexes that can be used:

Index code	Element
ti	article title
au	author
kw	article keywords
subject	subject (title words, abstract and keywords)
ab	abstract
ta	journal short title (e.g. Cad. Saúde Pública)
journal_title	journal full title (e.g. Cadernos de Saúde Pública)
la	publication language code (e.g. pt - Portuguese, es - Spanish)
type	document type
pid	publication identifier
publication_year	publication year of publication
sponsor	sponsor
aff_country	country code of the author's affiliation
aff_institution	author affiliation institution
volume	article volume
issue	article issue
elocation	elocation
doi	DOI number
issn	journal ISSN
in	SciELO colection code (e.g. scl - Brasil, col - Colômbia)
use_license	article usage license code

SciELO - Scientific Electronic Library Online
Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil
Email: scielo@scielo.org

All the contents of this site www.scielo.br, except where otherwise noted, is licensed under a Creative Commons Attribution License.
more »